5WK Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Aligos Therapeutics Inc

Watchlist Manager

Watchlist

Price: 10.725 EUR Market Closed

Market Cap: €837.7m

	Aligos Therapeutics Inc F:5WK	US
S	Singapore Telecommunications Ltd OTC:SGAPY	SG
H	Hannon Armstrong Sustainable Infrastructure Capital Inc F:6HA	US
D	Diamondback Energy Inc F:7DB	US
D	Daikin Industries Ltd F:DKI	JP
	Mueller Die lila Logistik SE F:MLL	DE
A	Advanced Micro Devices Inc BMV:AMD	US
	Ammo Inc F:92P	US
E	EOG Resources Inc XMUN:EO5	US
P	Publicis Groupe SA XMUN:PU4	FR
B	BNP Paribas SA DUS:BNP	FR

Profitability Summary

Aligos Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Negative Operating Margin

-4.025%

Negative 3Y Average Operating Margin

-1.666%

Declining Operating Margin

-586% > -4.025%

Negative Net Margin

-1.107%

Negative 3Y Average Net Margin

-1.396%

Declining Net Margin

-593% > -1.107%

Negative Free Cash Flow Margin

-3.794%

Negative 3Y Average Free Cash Flow Margin

-1.553%

Declining Free Cash Flow Margin

-582% > -3.794%

Negative ROE

-197%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-753%

Declining ROIC

-425% > -1.031%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.